FDA Cracking Down On Statements Made At Exhibit Booths
In a story appearing today (July 30) in the Wall Street Journal, the Food and Drug Administration is reported to be cracking down on companies whose sales representatives make improper statements about pharmaceutical products at medical conventions.
According to the story, the FDA has cited pharmaceutical firms in at least nine recent cases for allowing representatives to make improper statements or presentations at exhibit booths. Monitoring booth conversations is a new development for the FDA, which usually reserves close scrutiny for print and broadcast media.
The recent shift to scrutiny of exhibit booth conversations is the result of complaints from doctors and competing firms, according to the Journal story.
Medical conference organizers may find it useful to revisit rules of conduct for representatives at exhibitor booths.
Want to use this article? Click here for options!
© 2012 Penton Media Inc.
Acceptable Use Policy blog comments powered by Disqus
Advertisement
The Meeting Planning Blog
NEW! Capsules Latest Posts
Advertisement
Sign Up for Our Free E-Newsletters
Meetings Collaborative
Rate your experience with meeting venues and suppliers.
| Powered by: Meetings Collaborative | |
Advertisement
Latest Webinar
Beyond Marketing: What Else Social Media Can Do for Your MeetingsThursday, May 24 | 2-3 p.m. EST
Most associations know that online social networks can be handy tools to spread the word about their meetings and events. But social media can do so much more than market. Our social media expert will uncover ways you can leverage social media to discover the educational content your members are craving, engage and energize your community, build relationships, and even simplify your meeting processes.
Register Now!
VIEW ALL ARCHIVED WEBINARS
